Gynaecomastia secondary to transdermal oestradiol used for androgen deprivation therapy: informed reality vs subjective fear Article

sustainable development goals

publication date

  • July 14, 2026

webpage

published in

keywords

  • adverse effects
  • androgen deprivation therapy
  • gynaecomastia
  • mastalgia
  • oestradiol
  • quality of life
  • shared decision-making